Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recurrent amiodarone pulmonary toxicity

A Chendrasekhar1, R A Barke, P Druck

  • 1University of Minnesota, Minneapolis, USA.

Southern Medical Journal
|January 1, 1996
PubMed
Summary

Amiodarone pulmonary toxicity (APT) can recur even after steroid withdrawal and re-treatment. This rare recurrence highlights challenges in managing this severe drug side effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ventral hernia mesh tack causes liver hemorrhage.

Hernia : the journal of hernias and abdominal wall surgery·2012
Same author

Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes.

Journal of molecular and cellular cardiology·2001
Same author

Role of mu-opioid receptor in immune function.

Advances in experimental medicine and biology·2001
Same author

Morphine modulates lymph node-derived T lymphocyte function: role of caspase-3, -8, and nitric oxide.

Journal of leukocyte biology·2001
Same author

Morphine directs T cells toward T(H2) differentiation.

Surgery·2001
Same author

Interleukin-4 regulates macrophage interleukin-12 protein synthesis through a c-fos mediated mechanism.

Surgery·2000

Area of Science:

  • Cardiology
  • Pulmonology
  • Pharmacology

Background:

  • Amiodarone is a critical antiarrhythmic medication.
  • Amiodarone-induced pulmonary toxicity (APT) presents a significant clinical challenge with high mortality.
  • Standard management involves drug cessation and corticosteroid administration.

Observation:

  • This case details a patient experiencing recurrent amiodarone pulmonary toxicity.
  • The recurrence occurred after steroid discontinuation.
  • Reinstatement of steroid therapy proved ineffective in this patient.

Findings:

  • Recurrent amiodarone pulmonary toxicity is exceptionally rare, with limited prior reports.
  • The patient's condition did not improve despite reintroducing steroid treatment.
  • This suggests potential limitations of standard treatment protocols in specific APT recurrence scenarios.

Implications:

  • This case underscores the need for vigilance in monitoring patients on amiodarone, even after initial treatment.
  • It highlights the possibility of refractory or recurrent amiodarone pulmonary toxicity.
  • Further research may be warranted to explore alternative or adjunctive therapies for recurrent or steroid-resistant APT.

Related Experiment Videos